Breast-Cancer Pill Reduced Recurrence, Death in Early-Stage Patients, Study Finds

A drug sold by AstraZeneca and Merck reduced the recurrence of breast cancer in women with an early but aggressive form of the disease, a long-running international study found.

Resorts World to Open in Las Vegas

The first new megacasino on the Strip in more than a...

Chewy CFO Says Broader Product Range Bearing Fruit in Higher Earnings

Mario Marte said pet retailer could post first net profit this...

Rising Inflation Looks Less Severe Using Pre-Pandemic Comparisons

Inflation fears loom as U.S. consumers deal with starkly higher prices...

Wage Gains at Factories Fall Behind Growth in Fast Food

Factory jobs for years paid significantly more than those in many...